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Abstract
Background: Medullary thyroid carcinomas (MTC) constitute about 5 to 7 % of thyroid
neoplasms. They originate from parafollicular C cells which produce Calcitonin, a hormone which
has an impact on calcium metabolism and represents the biochemical activity of MTC. In rare cases
pre-operative serum calcitonin can be negative.
Case presentation: We report on a 73-year-old female patient with a rare case of a serum
calcitonin negative medullary thyroid carcinoma who suffered fulminant post-operative course and
died of multiple metastasis.
Conclusion: This case shows that in very rare cases MTCs do not secrete calcitonin making
diagnosis and tumour follow-up difficult. To this date, only few reports describing this combination
of circumstances were found in the English literature.
Background
Medullary thyroid carcinomas (MTC) constitute about 5
to 7 % of thyroid neoplasms. They originate from parafol-
licular C cells which are derived from the ultimobranchial
body and neural crest [1]. C cells produce Calcitonin, a
hormone which has an impact on calcium metabolism.
Microscopically the tumor is characterized by small nests
of small, round cells, production of amyloid and dense
irregular areas of calcification [1]. Cervical lymph node
metastases occur early in the disease in about 50 % of
cases with distant metastases occurring later. Cervical
metastases most commonly involve the central, paratra-
cheal and jugular regions. Distant metastases favor the
mediastinum, liver, lung and bone [2]. The incidence in
male/female ratio is roughly equal over a wide age range.
Most of MTC are sporadic and usually unilateral. Familial
medullary carcinoma occurs in the multiple endocrine
neoplasia syndromes (MEN) of the type 2 variety. When
occurring in association with MEN syndromes it is usually
bilateral and typically the first abnormality observed in
both MEN 2A and 2B syndromes.
The biochemical activity of medullary thyroid carcinoma
includes production of calcitonin and cacinoembryogenic
antigen (CEA). In rare cases pre-operative serum calci-
tonin can be negative. To this date, only few reports
describing this combination of circumstances were found
in the English literature [3-5].
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We report on a 73-year-old female patient with an 8-year
history of thyroid nodules for which she underwent regu-
lar clinical examination and blood tests. Three weeks
before referral to our endocrinological surgery unit she
developed a swelling of her head and neck lymph nodes.
Her past medical history included surgical removal of a
benign breast tumor 22 years ago. Her family history was
unremarkable regarding any endocrinological or thyroid
disease. Besides her obesity she was suffering from reflux
disease and hypertension. She had a regular pulse of 68/
per minute and blood pressure of 120/70 mmHg under
antihypertensive medication. Her muscle tone was
reduced. She had observed a change of her voice and had
lost 20 kg of weight within the past 4 months. A thyroid
scintigram showed multiple confluencing cold nodules
which were highly suspicious for malignant neoplasm of
both thyroid lobes and regional lymph node metastases
along both jugular veins. Clinical exam and sonography
showed multiple enlarged lymph nodes of the head and
neck. Pre-operative serum calcitonin was 5.3 pg/ml (nor-
mal range 0.8–9.9 pg/ml). Based on the history, clinical
presentation and the scintigram we suspected an anaplas-
tic thyroid carcinoma and performed a radical oncologic
thyroidectomy with bilateral modified neck-dissection
and resection of the right internal jugular vein and the left
recurrent laryngeal nerve. Intraoperatively the tumor was
tightly adherent to the surface of the trachea. Because of
the impressing clinical picture a fine needle aspiration was
not performed prior to surgery. In the authors' point of
view it would have had no prognostic effect at this
advanced stage of disease. A pre-operative pentagastrin
test was also not performed as clinical presentation made
the presence of an anaplastic carcinoma highly suspicious.
Surprisingly, histopathology showed a pT3 L1 V1 R1 N1b
low-differentiated medullary-thyroid carcinoma with
massive lymphangiosis and haemangiosis carcinomatosa.
Immunhistochemistry revealed weak positive staining for
calcitonin and carcinoembryogenic antigen (CEA) (Figure
1). Post-operative serum calcitonin decreased to 2.47 pg/
ml still being within normal range (0.8–9.9 pg/ml). Post
operatively the patient was in the intensive care unit for 6
days. A pentagastrin stimulation test was not performed
due to the bad condition of the patient. A permanent tra-
cheostoma was established to ensure a patent airway as
the patient aspirated after initial extubation. Additionally
massive crust formation obstructed the patient's airway
which was treated with a humidifier and frequent irriga-
tions with physiological saline solution and subsequent
suctioning of the trachea. Unfortunately the patient devel-
oped central lung emboli in the right pulmonary artery. A
postoperative CT scan showed multiple lung and intracer-
ebral metastases (Figure 2 and Figure 3). The patient died
six weeks after diagnosis.
Discussion
Medullary thyroid carcinoma is a rare calcitonin-secreting
neoplasm that occurs in both a familial and sporadic form
[6]. It is the most aggressive well differentiated thyroid
carcinoma, with survival rates of 40–50 % at 10 years [7].
Routine measurements of serum calcitonin levels are con-
sidered to be an integral part of the diagnostic evaluation
of thyroid nodules and the diagnosis of medullary thyroid
carcinoma. It has been suggested that calcitonin testing,
both with and without pentagastrin stimulation, may
facilitate early diagnosis of this disease and ultimately
decrease morbidity and mortality [8-12]. Serum CT is the
most specific and sensitive marker of MTC for both the
primary diagnosis and the postsurgical follow-up [13]; it
is produced in abnormally high concentrations by almost
100 % of primary and metastatic MTCs. However in rare
cases, as described here, serum calcitonin can be negative.
Although our patient had a voluminous, rapidly growing
medullary thyroid carcinoma with multiple metastases
pre-operative serum calcitonin was within normal range.
An calcitonin assay-specific problem is unlikely because
different assays were used postoperatively (Nicols Advan-
tage Chemiluminescence Assay, Nichols Institute Diag-
nostics Inc., San Clemente, CA, USA and Immulite
Calcitonin Assay, DPC-Bühlmann GmbH, Salzburg, Aus-
tria). Before referral to our department the patient's thy-
roid nodules were monitored by annual checks of thyroid
hormone and serum calcitonin. One would expect that
the expression of an antigen in the neoplastic cells would
be associated with the hypersecretion of the correspond-
ing antigen in the circulation, as in the case of Calcitonin
and CEA. The levels of these antigens are described to be
elevated in patients with metastastatic medullary thyroid
carcinoma and as accurate reflections of new metastases
[12-15]. Regrettably this was not the case in our patient. It
is possible that rare forms of MTC go along with muta-
tions in the calcitonin/CGRP gene which might be
responsible for the normal or relatively reduced calcitonin
levels. It would be interesting to examine the calcitonin/
CGRP gene structure in these patients. Analysis of white
blood cell DNA by Southern blot hybridizations could
show deletions or rearrangements in the calcitonin/CGRP
gene locus. Additionally defects in the cellular machinery
needed for calcitonin synthesis and/or secretion could be
responsible. The tumour showed positivity for calcitonin
in the immunhistochemistry which is in line with the lat-
ter hypothesis that calcitonin production is active but
secretion mechanisms might be altered. Bockhorn et al.
also reported a similar case of a 50 year old woman with
a serum calcitonin negative MTC. Comparing the histolo-
gies we have observed some (uncharacteristic) similari-
ties: the cells described were also relatively large with an
increased caryoplasmic ratio, indistinct cell borders and
partly spindled cytoplasm. It would be interesting to com-Page 2 of 4
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MTC's which might show histomorphologic similarities.
This report illustrates that in rare cases the diagnosis of
medullary thyroid carcinoma cannot be excluded by means of laboratory values such as serum calcitonin.
When serum calcitonin is negative a cytomorphologic
analysis of fine needle aspiration and a determination of
RET proto-oncogene mutations are two diagnostic tools
which are available for detection and accurate manage-
ment of patients in whom medullary thyroid carcinoma is
expected [16].
Conclusion
This case shows that in very rare cases MTCs do not secrete
calcitonin making diagnosis and tumour follow-up diffi-
cult.
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